openPR Logo
Press release

Remdesivir Market Size and Forecast 2021-2030 | COVID-19 Growth And Change

04-09-2021 06:44 AM CET | Health & Medicine

Press release from: The Business research company

Remdesivir Market

Remdesivir Market

New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The global remdesivir market is expected to grow from $1.98 billion in 2020 to $2.55 billion in 2021 at a compound annual growth rate (CAGR) of 28.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.89 billion in 2025 at a CAGR of 28%.

The Business Research Company offers " Remdesivir Global Market Report 2021: COVID-19 Growth And Change To 2030 " in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3253

The remdesivir market consists of sales of remdesivir drugs currently found effective in treating the COVID-19 disease. Remdesivir (RDV) is one of the promising drugs used currently for the treatment of the COVID-19 disease. Gilead, the US drug manufacturer is expanding its Remdesivir production due to the high demand for this drug. RDV is a synthetic compound throughout the class of antiviral drugs that target RNA synthesis.

Some of the key players involved in the Remdesivir Market are Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, and Dr. Reddy’s Laboratories.

The countries covered in the global Remdesivir Market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global Remdesivir Market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global Remdesivir Market is segmented -
1) By Route Of Administration: Oral, Intravenous
2) By Dosage Form: Tablets, Frozen Solution, Lypholized Solution
3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/remdesivir-market-global-report-2020-30-covid-19-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Remdesivir Market Characteristics
3. Remdesivir Market Trends And Strategies
4. Impact Of COVID-19 On Remdesivir Market
5. Remdesivir Market Size And Growth
.....
26. Africa Remdesivir Market
27. Remdesivir Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Remdesivir Market
29. Remdesivir Market Future Outlook and Potential Analysis
30. Appendix

The report covers the trends and market dynamics of the Remdesivir Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3253&type=smp

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About Us:
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Remdesivir Market Size and Forecast 2021-2030 | COVID-19 Growth And Change here

News-ID: 2268093 • Views:

More Releases from The Business research company

Optical Character Recognition (OCR) Systems Market Analysis, Size, Share, Latest Trends, Growth, And Forecast To 2033
Optical Character Recognition (OCR) Systems Market Analysis, Size, Share, Latest …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Optical Character Recognition (OCR) Systems Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The optical character recognition (ocr) systems market size has
Neural Network Software Market Report 2024: Latest Insights, Growth Rate, Future Trends And Forecast To 2033
Neural Network Software Market Report 2024: Latest Insights, Growth Rate, Future …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Neural Network Software Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The neural network software market size has grown exponentially in recent
Molecular Cytogenetics Market Analysis, Business Development, Size, Forecast To 2033
Molecular Cytogenetics Market Analysis, Business Development, Size, Forecast To …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Molecular Cytogenetics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The molecular cytogenetics market size has grown rapidly in recent years. It
Military Electro-Optics/Infrared (EO/IR) Systems Market Size, Share, Growth, Latest Trends, Forecast By 2033
Military Electro-Optics/Infrared (EO/IR) Systems Market Size, Share, Growth, Lat …
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Military Electro-Optics/Infrared (EO/IR) Systems Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The military electro-optics/infrared (eo/ir) systems market size has grown strongly

All 5 Releases


More Releases for Remdesivir

Remdesivir Market Share, Demand Analysis, Growth, Trends and Forecast - 2028
The global remdesivir market is anticipated to grow at a CAGR of 6.0% during the forecast period (2022- 2028). Remdesivir (RDV) is one of the promising drugs for the treatment of the COVID-19 disease. The FDA has approved an Emergency Use Authorization to allow adults and children who are hospitalized with severe COVID-19 to receive Remdesivir. Remdesivir is a broad spectrum anti-viral medication which was firstly developed by Gilead
Remdesivir Medicine Market Is Booming Worldwide with Gilead Sciences, Sanofi, Gl …
Advance Market Analytics published a new research publication on “Remdesivir Medicine Market Insights, to 2026″ with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Remdesivir Medicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Remdesivir Market Size, Opportunity Analysis, Shares & Forecast 2020-2027
Remdesivir Market report published by Value Market Research is an in-depth analysis of the market covering its size, share, value, growth and current trends for the period of 2020-2027 based on the historical data. This research report delivers recent developments of major players with their respective market share. In addition, it also delivers detailed analysis of regional and country market. The research report also covers the comprehensive profiles of the key
Remdesivir Market Size & Growth Rate, Emerging Trends, Main Vendors, and Forecas …
Remdesivir is a less popular drug for antiviral medication, which has become the first medicine approved by the FDA for treating the novel Coronavirus in May 2020. Previously, the drug Remdesivir was regarded as an investigational drug. The drug was never used to treat any disease or any medical condition. Today, the drug is being studied as a probable treatment for several diseases. In the beginning, the drug was created
Hetero Healthcare set to supply Covid-19 drug Remdesivir under brand name COVIFO …
Hetero’s group company ‘Hetero Healthcare Limited’ is all set to supply 20,000 vials of Covifor (Remdesivir)across the country. Following the approval of ‘COVIFOR’, the generic of Remdesivir by DCGI, Hetero Healthcare Limited, a group company of Heterois set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of
Remdesivir (COVID-19) Market Trends, Growth, Industry Analysis and Forecast 2025
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the corona virus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Remdesivir (COVID-19) market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and